Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
-
Published:2019-01-04
Issue:4
Volume:98
Page:897-907
-
ISSN:0939-5555
-
Container-title:Annals of Hematology
-
language:en
-
Short-container-title:Ann Hematol
Author:
Hüttmann Andreas, Rekowski Jan, Müller Stefan P., Hertenstein Bernd, Franzius Christiane, Mesters Rolf, Weckesser Matthias, Kroschinsky Frank, Kotzerke Jörg, Ganser Arnold, Bengel Frank M., La Rosée Paul, Freesmeyer Martin, Höffkes Heinz-Gert, Hertel Andreas, Behringer Dirk, Prange-Krex Gabriele, Griesshammer Martin, Holzinger Jens, Wilop Stefan, Krohn Thomas, Raghavachar Aruna, Maschmeyer Georg, Brink Ingo, Schroers Roland, Gaska Tobias, Bernhard Helga, Giagounidis Aristoteles, Schütte Jochen, Dienst Ariane, Hautzel Hubertus, Naumann Ralph, Klein Alfred, Hahn Dennis, Pöpperl Gabriele, Grube Matthias, Marienhagen Jörg, Schwarzer Andreas, Kurch Lars, Höhler Thomas, Steiniger Heike, Nückel Holger, Südhoff Thomas, Römer Wolfgang, Brinkmann Marcus, Ose Claudia, Alashkar Ferras, Schmitz Christine, Dürig Jan, Hoelzer Dieter, Jöckel Karl-Heinz, Klapper Wolfram, Dührsen UlrichORCID
Funder
Amgen Deutsche Krebshilfe Roche
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference27 articles.
1. Dührsen U, Müller S, Hertenstein B et al (2018) Positron-emission tomography-guided therapy of aggressive non-Hodgkin lymphomas (PETAL): a multicenter, randomized phase 3 trial. J Clin Oncol 36:2024–2034 2. Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, Ludwig WD, Klingebiel T, Graf N, Gruhn B, Juergens H, Niggli F, Parwaresch R, Gadner H, Riehm H, Schrappe M, Reiter A, BFM Group (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 105:948–958 3. Hoelzer D, Walewski J, Döhner H et al (2014) Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood 124:3870–3879 4. Lin C, Itti E, Haioun C, Petegnief Y, Luciani A, Dupuis J, Paone G, Talbot JN, Rahmouni A, Meignan M (2007) Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis. J Nucl Med 48:1626–1632 5. Müller C, Murawski N, Wiesen MH et al (2012) The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL. Blood 119:3276–3284
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|